{"id":39349,"date":"2020-11-04T14:24:40","date_gmt":"2020-11-04T14:24:40","guid":{"rendered":"https:\/\/setterwalls.se\/case\/setterwalls-has-assisted-ossdsign-in-connection-with-the-acquisition-of-sirakoss-and-subsequent-directed-share-issue\/"},"modified":"2022-02-14T13:44:15","modified_gmt":"2022-02-14T13:44:15","slug":"setterwalls-has-assisted-ossdsign-in-connection-with-the-acquisition-of-sirakoss-and-subsequent-directed-share-issue","status":"publish","type":"assignments","link":"https:\/\/setterwalls.se\/en\/case\/setterwalls-has-assisted-ossdsign-in-connection-with-the-acquisition-of-sirakoss-and-subsequent-directed-share-issue\/","title":{"rendered":"Setterwalls has assisted OssDsign in connection with the acquisition of Sirakoss and subsequent directed share issue"},"content":{"rendered":"<p><strong>Setterwalls has assisted OssDsign AB (publ) in connection with the acquisition of Sirakoss Ltd, a Scottish bone graft specialist company. In connection with the acquisition, OssDsign carried out a directed share issue to a number of Swedish and international investors.<\/strong><\/p>\n<p>The acquisition encompassed all outstanding shares in Sirakoss in an all-cash transaction, which is subject to customary closing conditions. The acquisition broadens OssDsign\u2019s product portfolio with the 510(k) cleared Osteo3 ZP Putty, a next-generation synthetic bone graft substitute for use in orthopaedic surgery. OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved healing of bone defects. OssDsign&#8217;s shares are listed on Nasdaq First North Growth Market. For further information about the acquisition and OssDsign, please refer to the company\u2019s <a href=\"https:\/\/www.ossdsign.com\/\">website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>Setterwalls has assisted OssDsign AB (publ) in connection with the acquisition of Sirakoss Ltd, a Scottish bone graft specialist company. In connection with the acquisition, OssDsign carried out a directed share issue to a number of Swedish and international investors.<\/strong><\/p>\n<p>The acquisition encompassed all outstanding shares in Sirakoss in an all-cash transaction, which is subject to customary closing conditions. The acquisition broadens OssDsign\u2019s product portfolio with the 510(k) cleared Osteo3 ZP Putty, a next-generation synthetic bone graft substitute for use in orthopaedic surgery. OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved healing of bone defects. OssDsign&#8217;s shares are listed on Nasdaq First North Growth Market. For further information about the acquisition and OssDsign, please refer to the company\u2019s <a href=\"https:\/\/www.ossdsign.com\/\">website<\/a>.<\/p>\n","protected":false},"author":1,"featured_media":34154,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":""},"class_list":["post-39349","assignments","type-assignments","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments\/39349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments"}],"about":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/types\/assignments"}],"author":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media\/34154"}],"wp:attachment":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media?parent=39349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}